C1 Esterase Inhibitor

Brand name: Haegarda

Rank #267 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$45.8M

Total Cost

Share:

894

Total Claims

$45.8M

Total Cost

46

Prescribers

$51K

Cost per Claim

0

Beneficiaries

894

30-Day Fills

$995K

Avg Cost/Provider

19

Avg Claims/Provider

Share of Medicare Part D Spending

0.02%

of total Medicare Part D spending

$45.8M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $45.8M total

🔎 Data Overview

💰

At $51,190 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $994,868 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of C1 Esterase Inhibitor

#ProviderSpecialtyLocationClaimsCost
1Sean BradyAllergy/ ImmunologyWilliamsville, NY13$5.1M
2Aleena BanerjiAllergy/ ImmunologyBoston, MA13$2.5M
3Maeve O'connorAllergy/ ImmunologyCharlotte, NC18$2.4M
4Marc RiedlAllergy/ ImmunologySan Diego, CA72$2.3M
5Marc RiedlAllergy/ ImmunologySan Diego, CA22$1.9M
6Douglas JonesAllergy/ ImmunologyLayton, UT13$1.8M
7Joshua JacobsAllergy/ ImmunologyWalnut Creek, CA40$1.8M
8David PettyAllergy/ ImmunologyIdaho Falls, ID13$1.8M
9Annie Arrey MensahAllergy/ ImmunologyFarmington Hills, MI19$1.7M
10Jane PurserInternal MedicineTulsa, OK55$1.4M
11Eric SchenkelAllergy/ ImmunologyBethlehem, PA11$1.4M
12Karen MaltbyAllergy/ ImmunologyTupelo, MS14$1.2M
13Jack GhablyAllergy/ ImmunologyAlbuquerque, NM13$1.0M
14Merritt FajtAllergy/ ImmunologyPittsburgh, PA12$998K
15Lisa CrandallNurse PractitionerMilwaukee, WI22$888K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
264Glipizide (Glipizide)$46.9M2,961,035
265Losartan/Hydrochlorothiazide (Losartan-Hydrochlorothiazide)$46.3M2,039,676
266Darunavir (Prezista)$46.0M21,793
267C1 Esterase Inhibitor (Haegarda)$45.8M894
268Alectinib Hcl (Alecensa)$45.7M2,686
269Ipratropium Bromide (Ipratropium Bromide)$45.4M656,249
270Amantadine Hcl (Amantadine)$45.2M173,840

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology